• GLYCOPYRROLATE chembl:CHEMBL1201027 ApprovedAntineoplastic

    Alternate Names:

    CHF5259
    NSC-250836
    AHR-504
    NSC-251252
    NVA237
    LONHALA MAGNAIR KIT
    GLYCOPYRRONE BROMIDE
    ROBINUL
    GLYCOPYRROLATE
    ORG-NC-45
    CUVPOSA
    NVA-237
    ROBINUL FORTE
    PT-001
    CHF-5259
    GLYCOPYRRONIUM BROMIDE
    ROBINUL FTE
    NSC-251251
    AD-237
    PT001
    SEEBRI
    GLYRX-PF
    SIALANAR

    Drug Info:

    Drug Indications for treatment of chronic obstructive pulmonary disorder (COPD)
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antineoplastic agent
    Drug Class adjuvants, anesthesia
    Year of Approval 1961
    (1 More Sources)

    Publications:

  • Interaction Score: 1.47

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Muscarinic acetylcholine receptor M1 antagonist
    Direct Interaction yes
    Trial Name glycopyrrolate, FHPC-02,Cuvposa

    PMIDs:
    None found


  • Interaction Score: 0.44

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Muscarinic acetylcholine receptor M3 antagonist
    Direct Interaction yes

    PMIDs:
    None found


    • Version: 01-August-2011

    Alternate Names:
    GLYCOPYRROLATE Primary Drug Name

    Drug Info:
    Year of Approval 1961
    Drug Class adjuvants, anesthesia

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0M0AM TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: